FDA warns shorter name of new Roche cancer drug may cause confusion

(Reuters) - The Food and Drug Administration warned on Monday that using a shorter name for Roche's new breast cancer drug Kadcyla may lead to the treatment being confused with an older therapy and cause potential harm to patients.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/D3Lk7BtmNOM/story01.htm

phlebotomy colleges phlebotomy training classes phlebotomy certification programs